Research
Efficacy of amlodipine as an adjunct to iron chelation therapy in reducing iron overload in thalassemia patients: a systematic review and meta-analysis
Nature ·
The Brief
- A systematic review and meta-analysis assesses amlodipine as an adjunct to iron chelation therapy in thalassaemia patients.
- The study's stated aim is reducing iron overload in these patients.
- The headline reports that the review finds amlodipine may aid iron chelation, but the source provides no further results.
Why it matters
Iron overload is a long-term complication for many thalassaemia patients, so a possible add-on to existing chelation therapy is of interest to clinicians and researchers, though the available source gives no detailed findings.
Who’s affected
- clinicians treating thalassaemia patients
- haematology researchers
- #thalassaemia
- #iron overload
- #chelation therapy
- #amlodipine
- #meta-analysis